RC
BMY icon

Rahlfs Capital’s Bristol-Myers Squibb BMY Stock Holding History

Rahlfs Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Hold
19,851
– – 0.84% 36
2026
Q1 		$1.2M Sell
19,851
-110
-0.6% -$6.41K 0.88% 38
2025
Q4 		$1.08M Hold
19,961
– – 0.84% 36
2025
Q3 		$900K Sell
19,961
-1,000
-5% -$46.7K 0.71% 42
2025
Q2 		$970K Hold
20,961
– – 0.89% 36
2025
Q1 		$1.28M Hold
20,961
– – 1.28% 23
2024
Q4 		$1.19M Buy
+20,961
New +$1.17M 1.17% 24

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Rahlfs Capital's BMY Position: Q2 2026 in Review

Rahlfs Capital held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 19,851 shares worth $1.14M. The position accounts for 0.84% of the portfolio, ranked #36.

Rahlfs Capital first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.28M in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Rahlfs Capital held 19,851 shares of Bristol-Myers Squibb worth $1.14M as of Q2 2026.
  • Rahlfs Capital left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.84% of Rahlfs Capital's portfolio in Q2 2026, its #36 holding.
  • Rahlfs Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Rahlfs Capital's Bristol-Myers Squibb position peaked at $1.28M in Q1 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Rahlfs Capital's 13F filing for Q2 2026, filed 28 Jul 2026.